Loading...

PE anti-mouse Ly-6G/Ly-6C (Gr-1) Antibody

Pricing & Availability
Clone
RB6-8C5 (See other available formats)
Regulatory Status
RUO
Other Names
Gr-1
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
RB6-8C5_PE_040912
C57BL/6 mouse bone marrow cells were stained with Ly-6G/Ly-6C (clone RB6-8C5) PE (filled histogram) or rat IgG2b, κ PE isotype control (open histogram). Data shown was gated on myeloid cell population.
  • RB6-8C5_PE_040912
    C57BL/6 mouse bone marrow cells were stained with Ly-6G/Ly-6C (clone RB6-8C5) PE (filled histogram) or rat IgG2b, κ PE isotype control (open histogram). Data shown was gated on myeloid cell population.
See PE spectral data
Cat # Size Price Save
108407 50 µg ¥12,320
108408 200 µg ¥40,260
Description

Gr-1 is a 21-25 kD protein also known as Ly-6G/Ly-6C. This myeloid differentiation antigen is a glycosylphosphatidylinositol (GPI)-linked protein expressed on granulocytes and macrophages. In bone marrow, the expression levels of Gr-1 directly correlate with granulocyte differentiation and maturation; Gr-1 is also transiently expressed on bone marrow cells in the monocyte lineage. Immature Myeloid Gr-1+ cells play a role in the development of antitumor immunity.

Product Details
Technical data sheet

Product Details

Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Raised against granulocytes of mouse origin
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Clone RB6-8C5 binds with high affinity to mouse Ly-6G molecules and to a lower extent to Ly-6C19. Clone RB6-8C5 impairs the binding of anti-mouse Ly-6G clone 1A819. However, clone RB6-8C5 is able to stain in the presence of anti-mouse Ly-6C clone HK1.420.

The RB6-8C5 antibody has been used to identify peripheral blood neutrophils and deplete granulocytes in vivo. Additional reported applications (for relevant formats of this clone) include: in vitro complement-mediated cytotoxicity2, in vivo depletion3-5,9, immunoprecipitation1, immunohistochemical staining6 (including paraffin-embedded sections9,16,33-35, acetone-fixed frozen sections11 and zinc-fixed sections15), and Western blotting7. RB6-8C5 is not suitable for depletion of hepatic myeloid derived suppressor cells (MDSCs)20.

Special Note: For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. No. 108436).

Application References

(PubMed link indicates BioLegend citation)
  1. Fleming TJ, et al. 1993. J. Immunol. 151:2399. (IP)
  2. Brummer E, et al. 1984. J. Leukocyte Biol. 36:505. (CMCD)
  3. Stoppacciaro A, et al. 1993. J. Exp. Med. 178:151. (Deplete)
  4. Tumpey TM, et al. 1996. J. Virol. 70:898. (Deplete)
  5. Czuprynski CJ, et al. 1994. J. Immunol. 152:1836. (Deplete)
  6. Nitta H, et al. 1997. Cell Vision 4:73. (IHC)
  7. Jutila MA, et al. 1988. Eur. J. Immunol. 18:1819. (WB)
  8. Engwerda CR, et al. 2004. Am. J. Pathol. 165:2123.
  9. Brown CR, et al. 2004. Infect. Immun. 72:4956. (Deplete, IHC)
  10. Andoniou CE, et al. 2005. Nature Immunology 6:1011. (FC) PubMed
  11. Li M, et al. 2006. P. Natl. Acad. Sci USA 103:11736. (IHC)
  12. Dzhagalov I, et al. 2007. Blood 109:1620. (FC) PubMed
  13. Fazilleau N, et al. 2007. Nature Immunol. 8:753. (FC) PubMed
  14. Heuser M, et al. 2007. Blood 110:1639. (FC) PubMed
  15. Wang T, et al. 2007. Infect. Immun. 75:1144. (IHC)
  16. Bosio CM, et al. 2007. J. Immunol. 178:4538. (IHC)
  17. Boehme SA, et al. 2009. Int. Immunol. 21:81. (IHC)
  18. Piao Y, et al. 2012. Neuro Oncol. 14:1379. PubMed
  19. Ribechini E, et al. 2009. Eur. J. Immunol. 39:3538.
  20. Ma C, et al. 2012. J. Leukoc. Biol. 92:1199.
  21. Li J, et al. 2012. Arthritis Rheum. 64:1098. PubMed
  22. Fan Q, et al. 2014. Cancer Res. 74:471. PubMed
  23. Korrer MJ, et al. 2014. PLoS One. 9:91370. PubMed
  24. Morshed M, et al. 2014. J Immunol. 192:5314. PubMed
  25. Collins C, et al. 2014. PNAS. 111:9899. PubMed
  26. Madireddi S, et al. 2014. J Exp Med. 211:1433. PubMed
  27. Bianchi G, et al. 2014. Cell Death Dis. 5:1135. PubMed
  28. Guo H, et al. 2014. J Leukoc Biol. 96:419. PubMed
  29. Roderick JE, et al. 2014. PNAS. 111:14436. PubMed
  30. Distel E, et al. 2014. Circ Res. 115:759. PubMed
  31. Iwai H, et al. 2015. Tuberculosis. 95:246. PubMed
  32. Charmsaz S, et al. 2015. PLoS One. 10:130692. PubMed
  33. Whiteland J, et al. 1994 J Histochem Cytochem 43:3 (IHC-P)
  34. Brown C, et al. 2003 J Immunology 171:2 (IHC-P)
  35. Obregon-Henao A, et al. PLoS One 8:11 (IHC-P)
Product Citations
  1. Lee Y, et al. 2017. PLoS One.. 10.1371/journal.pone.0183028. PubMed
  2. Hawila E, et al. 2017. Cell Rep.. 10.1016/j.celrep.2017.10.104. PubMed
  3. Hönes J, et al. 2017. Sci Rep. . 10.1038/s41598-017-15866-9. PubMed
  4. Moriyasu T, et al. 2018. PLoS Negl Trop Dis. 12:e0006197. PubMed
  5. Wang Q, et al. 2018. Int J Biol Sci. 14:147. PubMed
  6. Xiang W, et al. 2018. Nat Commun. 9:2574. PubMed
  7. Curtis MW, et al. 2018. Infect Immun. 86:e00186. PubMed
  8. Kunimoto H, et al. 2018. Cancer Cell. 33:44. PubMed
  9. Chinta KC et al. 2018. Cell reports. 25(7):1938-1952 . PubMed
  10. Alissafi T, et al. 2018. J Clin Invest. 128:3840. PubMed
  11. Cao W, et al. 2017. Immunity. 47:1182. PubMed
  12. Grzelak A, et al. 2018. Int J Mol Sci. 19:. PubMed
  13. Ibrahim ML, et al. 2018. Cell Rep. 25:3036. PubMed
  14. Cantor DJ et al. 2019. Cell reports. 26(1):108-118 . PubMed
  15. Dey A et al. 2019. The EMBO journal. 38(7) pii: e100293. PubMed
  16. Li J, et al. 2019. JCI Insight. 5. PubMed
  17. LaFleur MW, et al. 2019. Nat Commun. 10:1668. PubMed
  18. Yue X, et al. 2019. Nat Commun. 10:2011. PubMed
  19. Cai Y, et al. 2019. Cell Rep. 27:3034. PubMed
  20. Hsia HC, et al. 2017. J Leukoc Biol. 101:1053. PubMed
  21. Song C, et al. 2019. Nat Commun. 10:3745. PubMed
  22. Tian D, et al. 2019. Nat Commun. 10:4246. PubMed
  23. Weckbach LT, et al. 2019. J Exp Med. 216:350. PubMed
  24. Tran NT, et al. 2019. Cell Rep. 28:3510. PubMed
  25. Baryawno N et al. 2019. Cell. 177(7):1915-1932 . PubMed
  26. Ioanna E Galani et al. 2017. Immunity. 46(5):875-890 . PubMed
  27. Deng Z, et al. 2017. Oncogene. 36:639. PubMed
  28. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  29. Suresh MV, et al. 2019. JCI Insight. 4:e133103. PubMed
  30. Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed
  31. Brunner JS, et al. 2020. Nat Commun. 0.757638889. PubMed
  32. LaFleur MW, et al. 2019. Nat Immunol. 20:1335. PubMed
  33. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  34. Guarnerio J, et al. 2018. Nat Commun. 9:66. PubMed
  35. Keshavarz M, et al. 2020. Virol J. 17:64. PubMed
  36. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  37. Zhang M, et al. 2019. Autophagy. 1.423611111. PubMed
  38. Muri J, et al. 2020. Cell Reports. 29(9):2731-2744.e4.. PubMed
  39. Viny AD, et al. 2019. Cell Stem Cell. 25:682. PubMed
  40. Fukushima T, et al. 2019. Cell Rep. 29:4144. PubMed
  41. Etxeberria I, et al. 2020. Cancer Cell. 36(6):613-629. PubMed
  42. Somerville TD, et al. 2020. eLife. 9:e53381.. PubMed
  43. Gordan S, et al. 2020. Cell Reports. 29(10):3033-3046.e4.. PubMed
  44. Merlo LM, et al. 2020. Clin Pathol. 13:2632010X20951812. PubMed
  45. Akk A, et al. 2019. Mol Immunol. 114:629. PubMed
  46. Mosa A, et al. 2009. Infect Immun. 77:2908. PubMed
  47. Voronov E, et al. 2010. Int Immunol. 1.086805556. PubMed
  48. Stumpfova M, et al. 2010. Cancer Res . 70:2962. PubMed
  49. Casey S, et al. 2011. Mol Endocrinol. 25:933. PubMed
  50. Weimershaus M, et al. 2012. J Immunol. 188:1789. PubMed
  51. Rashid O, et al. 2013. Surgery. 153:771. PubMed
  52. Beyerle A, et al. 2011. J Control Release. 151:51. PubMed
  53. Ostapoff K, et al. 2013. Mol Cancer Ther. 12:1190. PubMed
  54. Liu X, et al. 2013. Diabetes. 62:4228. PubMed
  55. Pashover-Schallinger E, et al. 2012. FASEB J. 26:3891. PubMed
  56. Huang J, et al. 2014. J Immunol. 192:1972. PubMed
  57. Jackson A, et al. 2014. J Leukoc Biol. 92:609. PubMed
  58. Feng M, et al. 2014. Int Immunopharmacol. 19:267. PubMed
  59. Aebischer D, et al. 2014. PLoS One. 9:99297. PubMed
  60. Martin R, et al. 2014. J Leukoc Biol. 96:151. PubMed
  61. Ostapoff K, et al. 2014. Cancer Res. 74:4966. PubMed
  62. Roderick J, et al. 2014. Proc Natl Acad Sci U S A. 111:14436. PubMed
  63. Filina J, et al. 2014. Cell Signal. 26:2138. PubMed
  64. Crnej A, et al. 2015. Invest Ophthalmol Vis Sci . 56:185. PubMed
  65. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  66. Hegde V, et al. 2015. J Immunol. 194:5211. PubMed
  67. Shen H, et al. 2015. Infect Immun . 83: 2694 - 2704. PubMed
  68. Paschall A, et al. 2015. J Immunol. 194: 2369-2379. PubMed
  69. Sido J, et al. 2015. J Leukoc Biol. 98: 435-447. PubMed
  70. Drobek A, et al. 2015. J Immunol. 195: 3416 - 3426. PubMed
  71. Patankar Y, et al. 2015. Am J Physiol Lung Cell Mol Physiol. 309: L902 - L913. PubMed
  72. Ohtsuki T, et al. 2016. J Virol. 90: 300 - 307. PubMed
  73. Su N, Xiong Y 2016. Sci Rep. 6:22658. PubMed
  74. Ramos-Sevillano E, et al. 2016. PLoS One. 12: 1005500. PubMed
  75. Lira R, et al. 2016. PLoS One. 11: 0157475. PubMed
  76. Peng J, et al. 2016. Nat Commun. 7:12029. PubMed
  77. Rowe R, et al. 2016. J Exp Med. 213: 1497 - 1512. PubMed
  78. Yoon Y, et al. 2016. Stem Cell Reports. 7:840-853. PubMed
  79. Swanson P, et al. 2016. PLoS Pathog. 12:e1006022. PubMed
  80. Aguilera T, et al. 2016. Nat Commun. 7:13898. PubMed
  81. Xie Y, et al. 2020. Endocrinology. 161:00:00. PubMed
  82. Iwanami N, et al. 2020. iScience. 23:101260. PubMed
  83. Cai Z, et al. 2020. Cell Rep. 31:107816. PubMed
  84. Liu YY, et al. 2020. Chin Med J (Engl). 133:1688. PubMed
  85. Aguilera TA, et al. 2020. Clin Cancer Res. 26:2972. PubMed
  86. Bagati A, et al. 2020. Cancer Cell. 39(1):54-67.e9. PubMed
  87. Nayak RR, et al. 2021. Cell Host Microbe. 29(3):362-377.e11. PubMed
  88. Riether C, et al. 2021. Cell Reports. 34(4):108663. PubMed
  89. He Y, et al. 2021. Cell Metabolism. 33(5):988-1000.e7. PubMed
  90. Evavold CL, et al. 2021. Cell. 184(17):4495-4511.e19. PubMed
  91. Kruta M, et al. 2021. Cell Stem Cell. :. PubMed
  92. Siolas D, et al. 2021. Cell Reports. 36:109578. PubMed
  93. Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed
  94. Pan H, et al. 2020. Mol Psychiatry. . PubMed
  95. Rodríguez L, et al. 2021. Biomolecules. 11: . PubMed
  96. Gordon RA, et al. 2020. PLoS One. 15:e0226396. PubMed
  97. Canton J, et al. 2021. Nat Immunol. 22:140. PubMed
  98. Cartwright ANR, et al. 2021. Cancer Immunol Res. 9:470. PubMed
  99. Grigsby SM, et al. 2021. Cancers (Basel). 13:. PubMed
  100. Chen J, et al. 2021. Oncol Lett. 21:409. PubMed
  101. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  102. Dang Y, et al. 2021. J Cancer. 12:7158. PubMed
  103. Becker W, et al. 2021. J Crohns Colitis. 15:1032. PubMed
  104. Matsushita Y, et al. 2021. J Bone Miner Res. 36:1145. PubMed
  105. Xu ZH, et al. 2021. Mediators Inflamm. 2021:8856326. PubMed
  106. Terlizzi M, et al. 2021. Cell Physiol Biochem. 55:539. PubMed
  107. Yan W, et al. 2021. Front Med (Lausanne). 8:752223. PubMed
  108. Koide S, et al. 2022. iScience. 25:103603. PubMed
  109. Du Y, et al. 2022. Nat Commun. 13:231. PubMed
  110. Yuan M, et al. 2022. Oxid Med Cell Longev. 2022:5479491. PubMed
  111. Hu J, et al. 2021. Sci Adv. 7:. PubMed
  112. Franklin R, et al. 2022. Nat Commun. 13:2350. PubMed
  113. Chen Y, et al. 2022. Life Sci. 306:120826. PubMed
  114. Aktories P, et al. 2022. Cell Rep Methods. 2:100260. PubMed
  115. Uslu M, et al. 2020. J Cell Physiol. 235:9644. PubMed
  116. Darlyuk-Saadon I, et al. 2021. FEBS J. 288:3978. PubMed
  117. Yang M, et al. 2021. Cancer Immunol Immunother. 70:2467. PubMed
  118. Hao L, et al. 2021. Br J Pharmacol. 178:4726. PubMed
  119. Xu X, et al. 2021. J Nanobiotechnology. 19:376. PubMed
  120. Jordan PM, et al. 2021. Pharmaceuticals (Basel). 14:. PubMed
  121. Mirshahi F, et al. 2022. Cell Rep. 38:110454. PubMed
  122. Balachandran Y, et al. 2022. J Innate Immun. :1. PubMed
  123. Han Y, et al. 2022. Int J Biol Sci. 18:5653. PubMed
  124. Kan C, et al. 2022. Bone Res. 10:62. PubMed
  125. Matsumura T, et al. 2022. Nat Commun. 13:7064. PubMed
  126. Li H, et al. 2022. Cancer Cell. 40:36. PubMed
  127. Xiong T, et al. 2022. Cancer Sci. 113:1955. PubMed
  128. Roberts LM, et al. 2022. Cancers (Basel). 14: . PubMed
  129. Albayrak E, et al. 2022. J Cell Biochem. 123:2009. PubMed
  130. Shang T, et al. 2022. Front Pharmacol. 13:1054176. PubMed
  131. Kodali S, et al. 2022. J Immunol. 208:1085. PubMed
  132. Ramdas B, et al. 2022. Mol Ther. 30:2505. PubMed
  133. Pomatto-Watson LCD, et al. 2022. Geroscience. 44:2471. PubMed
  134. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  135. Brunner SM, et al. 2023. Int J Mol Sci. 24:. PubMed
  136. Dang YZ, et al. 2023. Neoplasma. 70:123. PubMed
  137. Li T, et al. 2023. Nat Commun. 14:2498. PubMed
  138. Ji Y, et al. 2023. Nat Cell Biol. 25:726. PubMed
RRID
AB_313372 (BioLegend Cat. No. 108407)
AB_313373 (BioLegend Cat. No. 108408)

Antigen Details

Structure
21-25 kD
Distribution

Granulocytes, monocytes

Cell Type
Granulocytes, Monocytes, Neutrophils
Biology Area
Immunology, Innate Immunity
Antigen References

1. Fleming TJ, et al. 1993. J. Immunol. 151:2399.
2. Jutila MA, et al. 1988. Eur. J. Immunol. 18:1819.
3. Goni O, et al. 2002. Int. Immunol. 14:1125.

Gene ID
17067 View all products for this Gene ID 546644 View all products for this Gene ID
UniProt
View information about Ly-6G Ly-6C on UniProt.org

Related FAQs

What type of PE do you use in your conjugates?
We use R-PE in our conjugates.
Go To Top Version: 2    Revision Date: 12/09/2013

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account